By Stella Qiu SYDNEY Asian sharemarkets started the last month of the year on a cautious note after

Lethal Company is estimated to have made over $5.4 million in sales after just three weeks on Steam and is showing no signs of slowing down.

Cardi B, G Eazy, Pharrell, MC Hammer, Will Smith, Chayanne, Nicki Minaj, and Pitbull are just a few of the artists Phil Wright has collaborated with

A district attorney in Tennessee has said his office has dropped 30 to 40 cases involving the five former officers who have been charged with second-degree murder in the January beating death of Tyre Nichols

The Maui police chief broke down in tears while explaining to reporters that the fire had melted metal, making it very difficult to identify remains

The head of the Wagner group, which in June attempted to topple Russia's military leadership, was registered to fly on a plane that crashed...

Arch-rivals Texas and Oklahoma meet Saturday in Dallas looking for an inside track to the Big 12 title game and big momentum toward the College Football Playoff

A Swiss court on Wednesday acquitted Islamic scholar Tariq Ramadan on charges of rape and sexual coercion, finding no evidence against...

Metallica earned themselves an extra four-legged fan after a dog that ran away from home ended up at the metal band's concert in Los Angeles. The doggo named Storm not only managed to sneak out of her home, but she even managed to take a seat at the So-Fi stadium show on August 27. In a tweet sharing the hound's humorous adventure, Metallica's official Twitter noted how "this dog did sure did have her day..." "You might have heard we had a four-legged fan join us for #M72LA! Despite reports to the contrary, our friend Storm snuck out of her home adjacent to @SoFiStadium and made her way to the gig all by herself." While Storm appeared to enjoy the show, she was safely reunited with her actual family the following day. "She had a great time listening to her favorite songs, including “Barx Æterna,” “Master of Puppies,” and “The Mailman That Never Comes.” Though the band doesn't recommend their M72 World Tour for dogs. “And in case you were wondering, no. You definitely shouldn’t bring your furry friends to the M72 World Tour. But this dog sure did have her day.” Fans of the band shared their amusement at this story Meanwhile, Storm was the only concertgoer to gain attention as actor Jason Momoa was spotted in the mosh pit from clips that have circulated on social media taken at the Metallica concert in California on August 25. “These f****** opened with ‘Whilplash’!” the Game Of Thrones and Aquaman star can be heard saying as the band began their set and Momoa joined the pit area. Sign up to our free Indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

Israel’s call for half of the Gaza Strip’s population to evacuate south is hiking Egypt’s fears of a massive influx of refugees across the border into its territory

Before last year’s midterms, the Supreme Court’s decision to strike down the right to an abortion galvanized Democrats.

A new survey has found that nearly half of adults in the United States are interested in taking prescription drugs for weight loss, such as Ozempic or Wegovy. In a KFF health tracking poll published on 3 August, researchers reported that 45 per cent of adults said they’d be interested in taking a “safe and effective” prescription drug for weight loss. Meanwhile, seven in 10 adults said they’ve heard at least “a little” about a new class of drugs being used for weight loss, with about one in five saying they have heard “a lot” about these drugs. Ozempic is a type 2 diabetes medication known for its weight loss side effects. Similar semaglutide injections, such as Wegovy and Mounjaro, have been specifically approved for the treatment of obesity and weight loss. This class of drugs called GLP-1 agonists works by mimicking a hormone called glucagon-like peptide 1 (GLP-1), regulating blood sugar levels and slowing down the rate at which food leaves the stomach to create the feeling of fullness. Of the US adults surveyed, older groups were some of the most aware of prescription weight loss drugs, with 76 per cent being those who have been told by a doctor in the past five years that they are overweight or obese. Nearly 60 per cent of those surveyed said they were currently trying to lose weight as well. While there was an overall interest in taking a prescription weight loss drug, that interest significantly decreased when people were asked whether they would take the medication as a routine injection. Only 16 per cent of adults said they would still take Ozempic or Wegovy, even if it wasn’t covered by their health insurance and was not specifically approved by the US Food and Drug Administration for weight loss. In fact, most people believed that insurance companies should cover the cost of weight loss drugs for adults who are overweight or obese, with an overwhelming 80 per cent of adults. Additionally, a large majority of adults believed the substantial profits that pharmaceutical companies have made from increased demand for weight loss drugs is a major factor contributing to the cost of injections like Ozempic and Wegovy. According to Novo Nordisk, the pharmaceutical company behind these prescription drugs for diabetes and weight loss, the list price for Ozempic can cost $935.77 per month without health insurance. Although the majority of adults said they trust pharmaceutical companies like Novo Nordisk to provide “reliable information” about safety and side effects of GLP-1 agonists, only 22 per cent said they trust these companies to price their products fairly. The FDA has listed the most common side effects of taking Wegovy as nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, and digestive disorders. More serious complications can occur from use of Wegovy or Mounjaro, such as the “potential risk of thyroid C-cell tumours,” pancreatitis, gallbladder problems, acute kidney injury, increased heart rate, and suicidal behaviour or thinking. Taking Ozempic can also lead to possible thyroid tumours, including cancer, pancreatitis, changes in vision, and kidney and gallbladder problems. Recently, several patients reported suffering from severe gastroparesis, also known as stomach paralysis, after taking the prescription weight loss medications. In a report from CNN, two people claimed that their “stomachs are paralysed” after taking Ozempic. “I wish I never touched it. I wish I’d never heard of it in my life,” Joanie Knight, a 37-year-old from Louisiana, told CNN. “This medicine made my life hell. So much hell. It has cost me money. It cost me a lot of stress; it cost me days and nights and trips with my family. It’s cost me a lot, and it’s not worth it. The price is too high.” One woman was also diagnosed with cyclic vomiting syndrome, which causes her to throw up multiple times a day. “I’ve almost been off Ozempic for a year, but I’m still not back to my normal,” said Emily Wright, a 38-year-old teacher from Toronto. Shortly after the report, the FDA shared in a statement with The Independent that it has become aware of stomach paralysis occurring among patients taking the medications. “The FDA has received reports of gastroparesis with semaglutide and liraglutide, of which some documented the adverse event as not recovered after discontinuation of the respective product at the time of the report,” the agency said. However, officials clarified that they were unable to determine whether taking Ozempic or Wegovy was the cause of stomach paralysis, or if it was caused by a different issue. “Gastroparesis can be a complication of diabetes that is related to long-standing or poorly controlled disease, further complicating the ability to determine what role the drugs played in the reported events,” the FDA added. In response to reports of stomach paralysis, drug manufacturer Novo Nordisk noted that these medications have been used to treat type 2 diabetes “for more than 15 years”, and for the “treatment of obesity” for eight years. “Semaglutide has been extensively examined in robust clinical development programs, large real world evidence studies and has cumulatively over 9.5 million patient years of exposure,” a spokesperson for Novo Nordisk said in a statement to The Independent. “Gastrointestinal (GI) events are well-known side effects of the GLP-1 class. For semaglutide, the majority of GI side effects are mild to moderate in severity and of short duration. GLP-1’s are known to cause a delay in gastric emptying, as noted in the label of each of our GLP-1 RA medications. Symptoms of delayed gastric emptying, nausea and vomiting are listed as side effects.” Read More Obese people on weight-loss jabs ‘should be prepared to stay on them for life’ Ozempic users report stomach paralysis as weight loss drug side effect: ‘I wish I never touched it’ Sharon Osbourne says she was ‘nauseous’ for weeks after taking Ozempic to lose weight Sharon Osbourne reveals what Ozempic did to her when she was taking it Ozempic users report stomach paralysis as side effect: ‘I wish I never touched it’ Lorraine Candy: ‘Perimenopausal rage made me unravel’